Prevalence of benefit finding and posttraumatic growth in long-term cancer survivors: results from a multi-regional population-based survey in Germany

• Published in: British journal of cancer 2021-09, Vol.125 (6), p.877-883
• Main Authors: Liu, Zhunzhun, Thong, Melissa S. Y., Doege, Daniela, Koch-Gallenkamp, Lena, Bertram, Heike, Eberle, Andrea, Holleczek, Bernd, Waldmann, Annika, Zeissig, Sylke Ruth, Pritzkuleit, Ron, Brenner, Hermann, Arndt, Volker
• Format: Article
• Language: English
• Subjects: 692/4028/67/2324; 692/700/478/174; Adaptation, Psychological; Adult; Age Factors; Aged; Biomedical and Life Sciences; Biomedicine; Breast cancer; Breast Neoplasms - psychology; Cancer; Cancer Research; Cancer Survivors - psychology; Colorectal cancer; Colorectal Neoplasms - psychology; Diagnosis; Drug Resistance; Epidemiology; Female; Germany - epidemiology; Humans; Male; Medical diagnosis; Middle Aged; Molecular Medicine; Oncology; Population studies; Post-traumatic growth; Posttraumatic Growth, Psychological; Prevalence; Prostate; Prostate cancer; Prostatic Neoplasms - psychology; Sex Factors; Young Adult
• ISSN: 0007-0920; 1532-1827
• DOI: 10.1038/s41416-021-01473-z

Background Cancer studies reported mixed results on benefit finding (BF) and posttraumatic growth (PTG) prevalence and few were focused on long-term survivors. Methods BF and PTG were assessed in a multi-regional population-based study in Germany with 6952 breast, colorectal and prostate cancer survivors, using the Benefit Finding Scale and Posttraumatic Growth Inventory. We calculated the age-adjusted prevalence, stratified by demographical and clinical characteristics. Results Overall, 66.0% of cancer survivors indicated moderate-to-high BF, and 20.5% moderate-to-high PTG. Age-adjusted prevalence of BF and PTG differed according to cancer type (breast > colorectal > prostate) and sex (female > male). BF and PTG prevalence were higher in younger than in older respondents; the age-adjusted prevalence was higher in respondents who survived more years after diagnosis. The strength and direction of associations of age-adjusted prevalence with cancer stage, disease recurrence, and time since diagnosis varied according to cancer type and sex. Conclusions A substantial proportion of long-term cancer survivors reported moderate-to-high BF and PTG. However, the prevalence was lower in older and male cancer survivors, and during the earlier years after cancer diagnosis. Further longitudinal studies on PTG and BF in cancer survivors are warranted to address heterogeneity in survivors’ experience after cancer diagnosis.